China Medical & HealthCare Group Limited Stock price

Equities

383

BMG2133H2006

Healthcare Facilities & Services

Market Closed - Hong Kong S.E. 04:08:03 2024-03-28 am EDT 5-day change 1st Jan Change
0.7 HKD +2.94% Intraday chart for China Medical & HealthCare Group Limited +2.94% -12.50%
Sales 2021 1.46B 187M Sales 2022 1.44B 184M Capitalization 796M 102M
Net income 2021 -137M -17.51M Net income 2022 -124M -15.85M EV / Sales 2021 0.95 x
Net Debt 2021 390M 49.89M Net Debt 2022 390M 49.8M EV / Sales 2022 0.82 x
P/E ratio 2021
-7.28 x
P/E ratio 2022
-6.44 x
Employees 2,599
Yield 2021 *
-
Yield 2022
-
Free-Float 21.4%
More Fundamentals * Assessed data
Dynamic Chart
China Medical & Healthcare Group Limited Proposes Ordinary Final Dividend for the Year Ended 31 December 2023, Payable on 02 August 2024 CI
China Medical & HealthCare Group Returns to Profit in 2023 on Higher Revenue MT
China Medical & HealthCare Group Limited Reports Earnings Results for the Full Year Ended December 31, 2023 CI
China Medical & HealthCare to Return to Profit in 2023 MT
China Medical & Healthcare Group Limited Provides Earnings Guidance for Eleven Months Ended 30 November 2023 CI
China Medical & HealthCare Names New Auditor MT
China Medical & HealthCare Proposes Name Change MT
China Medical & Healthcare Group Limited Announces Company Secretary and Authorised Representative Changes CI
China Medical & HealthCare Group Limited Announces Change in the Composition of the Board of Directors and Change of Members of the Board Committees CI
Fareast Global, TACI Conclude CMH Offer; Assume Control of Target MT
China Medical & Healthcare Group Limited Announces Resignation of Chong Sok Un as Executive Director and Deputy Chairman and Change in Composition of the Board Committees CI
Tian An China Investments Company Limited (SEHK:28) completed the acquisition of 18.13% stake in China Medical & HealthCare Group Limited from its shareholders for approximately HKD 180 million. CI
China Medical & HealthCare Group's H1 Attributable Loss Narrows MT
China Medical & HealthCare Group Limited Reports Earnings Results for the Half Year Ended June 30, 2023 CI
China Medical & HealthCare's January-May Loss Seen to Narrow By Up to 97% MT
More news
1 day+2.94%
1 week+2.94%
3 months-12.50%
6 months-19.54%
Current year-12.50%
More quotes
1 week
0.68
Extreme 0.68
0.70
1 month
0.66
Extreme 0.66
0.70
Current year
0.60
Extreme 0.6
0.93
1 year
0.60
Extreme 0.6
1.08
3 years
0.60
Extreme 0.6
2.54
5 years
0.60
Extreme 0.6
5.80
10 years
0.60
Extreme 0.6
13.88
More quotes
Managers TitleAgeSince
Director/Board Member 58 22-10-26
Members of the board TitleAgeSince
Director/Board Member 60 23-10-09
Director/Board Member 64 16-12-07
Chairman 55 23-10-09
More insiders
Date Price Change Volume
24-03-28 0.7 +2.94% 0
24-03-27 0.68 0.00% 0
24-03-26 0.68 0.00% 5,000
24-03-25 0.68 0.00% 15,710
24-03-22 0.68 0.00% 0

Delayed Quote Hong Kong S.E., March 28, 2024 at 04:08 am EDT

More quotes
China Medical & HealthCare Group Ltd is an investment holding company principally engaged in the healthcare business. The Company operates its business through six segments. The Healthcare segment is engaged in the operation of hospitals in China. The Eldercare segment is engaged in the property development of independent living units and project management of health campus in China with focus on elderly care and retirement community, which consist of an elderly nursing home, service apartments, independent living units and a commercial area comprising a shopping mall, retail shops and club hall facilities. The Property Development segment is engaged in the development and sale of properties and land. The Property Investment segment is engaged in the leasing of residential and office properties. The Financial Services segment provides loan financial services. The Securities Trading and Investments is engaged in the trading of securities in Hong Kong and overseas markets.
More about the company
  1. Stock
  2. Equities
  3. Stock China Medical & HealthCare Group Limited - Hong Kong S.E.